• Lutathera may Improve Quality of Life in Midgut Neuroendocrine Tumors

    11 monthes ago - By Medindia Health

    Lutathera, a newly approved drug, provides improved quality of life for midgut neuroendocrine tumor patients while enhancing progression-free survival. The drug consists of a somatostatin analog combined with a radioactive isotope that directly targets neuroendocrine tumor cells.
    Read more ...